In The News

If the cost of creating new drugs is high, the cost of not having any new drugs is immeasurable.

The Jewish vote goes overwhelmingly to Democratic candidates. But could President Obama’s deal with Iran erode that grip? And would it make any difference in the next presidential election?

Looking at the long list of IRS abuses, something needs to be done.

As venues and ticketing companies attempt to monopolize secondary ticket markets, now is the time for governments to address this issue and act to protect consumers' rights.

The U.S. has gone from asking "Where can we get more oil?" to "Where can we put it?" The US can ease the storage crunch and leverage the energy boom to the benefit of the U.S. economy by lifting the export ban on oil and natural gas.

At the end of the 113th Congress, lawmakers kicked the proverbial can down the road when they left the issue of taxing internet access to the 114th Congress.  Will 2015 be the year something changes?

It’s time to end the cycle of the feds taking our money only to hand some of it back—minus a big bureaucratic handling charge—if states do their bidding.

A federal policy think-tank this week released a new document detailing the impacts of tax uncertainty on the ag sector, including the "will they or won't they" nature of Section 179 reinstatement. In commentary on Section 179 and ag tax issues, IPI President Tom Giovanetti says Congress' latest move on the 2014 expensing provision was essentially too little too late.

Those fighting to keep Medicare from becoming a means-tested welfare program are losing the battle, but that might be the only way we’re ever going to get real Medicare reform.

If Obama gets a deal, don’t be surprised if the agreement stresses ending the sanctions first and compliance verification second.